{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:21:54Z","timestamp":1791591714313,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11556-4","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:53:20Z","timestamp":1758088400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of antibodies against rubella virus, cytomegalovirus, hepatitis b, and Toxoplasma gondii in women of reproductive age prior to conception in Iran"],"prefix":"10.1186","volume":"25","author":[{"given":"Nasser","family":"Hajipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Mohammady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"barzegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"11556_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clp.2014.11.001","volume":"42","author":"N Neu","year":"2015","unstructured":"Neu N, Duchon J, Zachariah P. Torch infections. Clin Perinatol. 2015;42:77\u2013103.","journal-title":"Clin Perinatol"},{"key":"11556_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3329\/jhpn.v29i1.7569","volume":"29","author":"N Kumari","year":"2011","unstructured":"Kumari N, Morris N, Dutta R. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from Eastern Nepal. J Health Popul Nutr. 2011;29:77.","journal-title":"J Health Popul Nutr"},{"key":"11556_CR3","first-page":"72","volume":"4","author":"W Yu","year":"2022","unstructured":"Yu W, Hu X, Cao B. Viral infections during pregnancy: the big challenge threatening maternal and fetal health. Matern Med. 2022;4:72\u201386.","journal-title":"Matern Med"},{"key":"11556_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/jmms.jmms_26_17","volume":"19","author":"M Kumar","year":"2017","unstructured":"Kumar M, Nizam MB, Mugunthan M. Seroprevalence of cytomegalovirus infection in antenatal women in a tertiary care center in Western India. J Mar Med Soc. 2017;19:51\u20134.","journal-title":"J Mar Med Soc"},{"key":"11556_CR5","doi-asserted-by":"crossref","unstructured":"Tonkin C. Toxoplasma gondii. 1st edition. New York: Springer; 2020.","DOI":"10.1007\/978-1-4939-9857-9"},{"key":"11556_CR6","first-page":"54","volume-title":"Motarjemi YBT-E of FS","author":"EM Hanafi","year":"2014","unstructured":"Hanafi EM, Ozkan AT, Bowman DD. Protozoa: Toxoplasma gondii. Motarjemi YBT-E of FS. editor. Waltham: Academic; 2014. pp. 54\u201362."},{"key":"11556_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307941","volume":"19","author":"F Hamidi","year":"2024","unstructured":"Hamidi F, Rostami A, Hosseini SA, Calero-Bernal R, Hajavi J, Ahmadi R, et al. Anti-Toxoplasma gondii IgG seroprevalence in the general population in Iran: a systematic review and meta-analysis, 2000\u20132023. PLoS One. 2024;19: e0307941.","journal-title":"PLoS One"},{"key":"11556_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.actatropica.2016.03.003","volume":"158","author":"M Foroutan-Rad","year":"2016","unstructured":"Foroutan-Rad M, Khademvatan S, Majidiani H, Aryamand S, Rahim F, Malehi AS. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: a systematic review and meta-analysis. Acta Trop. 2016;158:160\u20139.","journal-title":"Acta Trop"},{"issue":"56","key":"11556_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/cga.12138","volume":"2016","author":"S Rasti","year":"2016","unstructured":"Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Gholam S, Mousavi A. ToRCH co-infections are associated with increased risk of abortion in pregnant women. Congenit Anomalies. 2016;2016(56):73\u20138.","journal-title":"Congenit Anomalies."},{"key":"11556_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.69613\/b8fczy88","volume":"2","author":"KM Dikole","year":"2024","unstructured":"Dikole KM, Kamble HV, Waghmare SA. A comprehensive review on Rubella virus. J Pharma Insights Res. 2024;2:103\u20137.","journal-title":"J Pharma Insights Res"},{"key":"11556_CR11","first-page":"169","volume":"13","author":"M Azami","year":"2019","unstructured":"Azami M, Jaafari Z, Soleymani A, Badfar G, Abbasalizadeh S. Rubella immunity in pregnant Iranian women: a systematic review and meta-analysis. Int J Fertil Steril. 2019;13:169.","journal-title":"Int J Fertil Steril"},{"key":"11556_CR12","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0140-6736(21)02691-X","volume":"399","author":"AK Winter","year":"2022","unstructured":"Winter AK, Moss WJ, Rubella. Lancet. 2022;399:1336\u201346.","journal-title":"Lancet"},{"key":"11556_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.15789\/2220-7619-2018-3-341-348","volume":"8","author":"AP Toptygina","year":"2018","unstructured":"Toptygina AP, Smerdova MA, Naumova MA, Vladimirova NP, Mamaeva TA. Influence of population immunity peculiarities on the structure of measles and rubella prevalence. Russ J Infect Immun. 2018;8:341\u20138.","journal-title":"Russ J Infect Immun"},{"key":"11556_CR14","first-page":"167","volume":"76","author":"A Shafayi","year":"2021","unstructured":"Shafayi A, Mohammadi A. A review on Rubella vaccine: Iran (1975\u20132019). Arch Razi Inst. 2021;76:167\u201392.","journal-title":"Arch Razi Inst"},{"key":"11556_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-5-44","volume":"5","author":"J Sadighi","year":"2005","unstructured":"Sadighi J, Eftekhar H, Mohammad K. Congenital Rubella syndrome in Iran. BMC Infect Dis. 2005;5:1\u20137.","journal-title":"BMC Infect Dis"},{"key":"11556_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/jp.2017.41","volume":"37","author":"TM Lanzieri","year":"2017","unstructured":"Lanzieri TM, Leung J, Caviness AC, Chung W, Flores M, Blum P, et al. Long-term outcomes of children with symptomatic congenital cytomegalovirus disease. J Perinatol. 2017;37:875\u201380.","journal-title":"J Perinatol"},{"key":"11556_CR17","first-page":"206","volume":"48","author":"M Sharghi","year":"2019","unstructured":"Sharghi M, Musavi H, Malekpour Mansurkhani S, Kooti W, Behzadifar M, Ashrafi-Zadeh H, et al. Seroprevalence of cytomegalovirus among women of reproductive age in iran: A systematic review and meta-analysis. Iran J Public Health. 2019;48:206\u201316.","journal-title":"Iran J Public Health"},{"key":"11556_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trim.2022.101587","volume":"72","author":"N Mesgar Saravi","year":"2022","unstructured":"Mesgar Saravi N, Mousavi T. Seroprevalence of cytomegalovirus antibodies and primary infection among hemodialysis patients: a systematic and meta-analysis review. Transpl Immunol. 2022;72:1\u201310.","journal-title":"Transpl Immunol"},{"key":"11556_CR19","first-page":"377","volume":"28","author":"M Belopolskaya","year":"2015","unstructured":"Belopolskaya M, Avrutin V, Firsov S, Yakovlev A. HBsAG level and hepatitis B viral load correlation with focus on pregnancy. Ann Gastroenterol. 2015;28:377\u201382.","journal-title":"Ann Gastroenterol"},{"key":"11556_CR20","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053\u201363.","journal-title":"Lancet"},{"key":"11556_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.35","volume":"4","author":"M-F Yuen","year":"2018","unstructured":"Yuen M-F, Chen D-S, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, et al. Hepatitis b virus infection. Nat Rev Dis Primers. 2018;4:1\u201320.","journal-title":"Nat Rev Dis Primers"},{"key":"11556_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00424-w","volume":"17","author":"Y Rostam-Abadi","year":"2020","unstructured":"Rostam-Abadi Y, Rafiemanesh H, Gholami J, Shadloo B, Amin-Esmaeili M, Rahimi-Movaghar A. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis. Harm Reduct J. 2020;17:1\u201319.","journal-title":"Harm Reduct J"},{"key":"11556_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/hepatmon.35577","volume":"16","author":"M Salehi-Vaziri","year":"2016","unstructured":"Salehi-Vaziri M, Sadeghi F, Hashiani AA, Fesharaki MG, Alavian SM. Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis. Hepat Mon. 2016;16:1\u20138.","journal-title":"Hepat Mon"},{"key":"11556_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-023-02560-4","volume":"23","author":"L Han","year":"2023","unstructured":"Han L, Li R, Xiong W, Hu Y, Wu J, Liu X, et al. Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in Southern China. BMC Womens Health. 2023;23:1\u201312.","journal-title":"BMC Womens Health"},{"key":"11556_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2020.00569","volume":"8","author":"T Singh","year":"2020","unstructured":"Singh T, Otero CE, Li K, Valencia SM, Nelson AN, Permar SR. Vaccines for perinatal and congenital infections\u2014how close are we?? Front Pediatr. 2020;8:1\u201322.","journal-title":"Front Pediatr"},{"key":"11556_CR26","unstructured":"Lwanga SK, Lemeshow S, Organization WH. Sample size determination in health studies: a practical manual\/SK Lwanga and S. Lemeshow. In: Sample size determination in health studies: a practical manual\/SK Lwanga and S. Lemeshow. 1991."},{"key":"11556_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.actatropica.2014.05.015","volume":"137","author":"A Daryani","year":"2014","unstructured":"Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014;137:185\u201394.","journal-title":"Acta Trop"},{"key":"11556_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1155\/2022\/4490728","volume":"2022","author":"E Nabizadeh","year":"2022","unstructured":"Nabizadeh E, Ghotaslou A, Salahi B, Ghotaslou R. The screening of Rubella virus, cytomegalovirus, hepatitis B virus, and Toxoplasma gondii antibodies in prepregnancy and Reproductive-Age women in tabriz, Iran. Infect Dis Obstet Gynecol. 2022;2022:2\u20136.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"11556_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1128\/CMR.15.4.680-715.2002","volume":"15","author":"MG Revello","year":"2002","unstructured":"Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15:680\u2013715.","journal-title":"Clin Microbiol Rev"},{"key":"11556_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jcv.2007.10.015","volume":"41","author":"T Lazzarotto","year":"2008","unstructured":"Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol. 2008;41:192\u20137.","journal-title":"J Clin Virol"},{"key":"11556_CR31","first-page":"665","volume":"185","author":"P Ambroise-Thomas","year":"2001","unstructured":"Ambroise-Thomas P, Schweitzer M, Pinon JM, Thiebaugeorges O. Prevention of congenital toxoplasmosis in france. Risk assessment. Results and perspectives of prenatal screening and newborn follow up. Bull Acad Natl Med. 2001;185:665\u201383.","journal-title":"Bull Acad Natl Med"},{"key":"11556_CR32","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1128\/JCM.39.5.1912-1916.2001","volume":"39","author":"M Paul","year":"2001","unstructured":"Paul M, Petersen E, Szczapa J. Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznan region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol. 2001;39:1912\u20136.","journal-title":"J Clin Microbiol"},{"key":"11556_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep22551","volume":"6","author":"H Wilking","year":"2016","unstructured":"Wilking H, Thamm M, Stark K, Aebischer T, Seeber F. Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in germany: a representative, cross-sectional, serological study. Sci Rep. 2016;6: 22551.","journal-title":"Sci Rep"},{"key":"11556_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/apm.12354","volume":"123","author":"G Findal","year":"2015","unstructured":"Findal G, Barlinn R, Sandven I, Stray-Pedersen B, Nordb\u00f8 SA, Samdal HH, et al. Toxoplasma prevalence among pregnant women in norway: a cross\u2010sectional study. APMIS. 2015;123:321\u20135.","journal-title":"APMIS"},{"key":"11556_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1017\/S0031182011001880","volume":"139","author":"X-J Gao","year":"2012","unstructured":"Gao X-J, Zhao Z-J, He Z-H, Wang T, Yang T-B, Chen X-G, et al. Toxoplasma gondii infection in pregnant women in China. Parasitology. 2012;139:139\u201347.","journal-title":"Parasitology"},{"key":"11556_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/aje\/154.4.357","volume":"154","author":"JL Jones","year":"2001","unstructured":"Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the united states: Seroprevalence and risk factors. Am J Epidemiol. 2001;154:357\u201365.","journal-title":"Am J Epidemiol"},{"key":"11556_CR37","first-page":"519","volume":"34","author":"M Harma","year":"2004","unstructured":"Harma M, Gungen N, Demir N. Toxoplasmosis in pregnant women in sanliurfa, southeastern Anatolia city, Turkey. J Egypt Soc Parasitol. 2004;34:519\u201325.","journal-title":"J Egypt Soc Parasitol"},{"key":"11556_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-5-66","volume":"5","author":"S Ertug","year":"2005","unstructured":"Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005;5:1\u20136.","journal-title":"BMC Public Health"},{"key":"11556_CR39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0213-005X(04)73152-3","volume":"22","author":"N Guti\u00e9rrez-Zufiaurre","year":"2004","unstructured":"Guti\u00e9rrez-Zufiaurre N, S\u00e1nchez-Hern\u00e1ndez J, Mu\u00f1oz S, Mar\u00edn R, Delgado N, S\u00e1enz MC, et al. Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, Rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm Infecc Microbiol Clin. 2004;22:512\u20136.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"11556_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1600-0897.2004.00222.x","volume":"52","author":"S Singh","year":"2004","unstructured":"Singh S, Pandit AJ. Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. Am J Reprod Immunol. 2004;52:276\u201383.","journal-title":"Am J Reprod Immunol"},{"key":"11556_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.34172\/ajcmi.3486","volume":"10","author":"R Ahmadi","year":"2023","unstructured":"Ahmadi R, Sadeghinasab J, Siyadatpanah A, Mirzaei F, Aghcheli B, Norouzi R. Frequency of Toxoplasma gondii, rubella, and cytomegalovirus antibodies in pregnant women in Yazd province, Iran. Avicenna J Clin Microbiol Infect. 2023;10:145\u201351.","journal-title":"Avicenna J Clin Microbiol Infect"},{"key":"11556_CR42","first-page":"164","volume":"10","author":"A Panah","year":"2013","unstructured":"Panah A, Soufiani K, Barzegar G, Gharachorlou A, Zeydi A. Seroprevalence of Toxoplasma gondii infection among pregnant women in amol, Northern Iran. Life Sci J. 2013;10:164\u20138.","journal-title":"Life Sci J"},{"key":"11556_CR43","doi-asserted-by":"crossref","unstructured":"Kanani B, Namaei MH, Tavakoli Kareshk A, Solgi R. Seroprevalence of Toxoplasma gondii infection among women of reproductive age in birjand, Iran. Mod Care J. 2022;19:1\u20135.","DOI":"10.5812\/modernc-127872"},{"key":"11556_CR44","doi-asserted-by":"publisher","unstructured":"Shakiba N, Farhadifar F, Bahmani N, Zareei M. Seroprevalence of toxoplasmosis infection in diabetic pregnant women from sanandaj, Kurdistan.West of Iran. 2020;1\u201312. Available from: https:\/\/doi.org\/10.21203\/rs.3.rs-29463\/v1 .","DOI":"10.21203\/rs.3.rs-29463\/v1"},{"key":"11556_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.53350\/pjmhs2216925","volume":"16","author":"S Karamat","year":"2022","unstructured":"Karamat S, Khan FA, Saeed S, Jafri A, Langhani SK, Saleem A. Occurrence of seropositivity of Toxoplasma gondii, cytomegalovirus, and Rubella infections in pregnant women. Pak J Med Health Sci. 2022;16:25.","journal-title":"Pak J Med Health Sci"},{"key":"11556_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011248","volume":"17","author":"VJ Hicks","year":"2023","unstructured":"Hicks VJ, S\u00e1nchez C, L\u00f3pez MR, Gottschlich A, Grajeda LM, Balish A, et al. Seroprevalence of high incidence congenital infections among pregnant women in Coatepeque, Guatemala and surrounding areas, 2017\u20132018. PLoS Negl Trop Dis. 2023;17: e0011248.","journal-title":"PLoS Negl Trop Dis"},{"key":"11556_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/puh2.82","volume":"2","author":"SO Addo","year":"2023","unstructured":"Addo SO, Asare TO, Arthur C, Amoateng K, Addo K, Larbi JA. Toxoplasma gondii among pregnant women attending antenatal care in a district hospital in Ghana. Public Health Challenges. 2023;2: e82.","journal-title":"Public Health Challenges"},{"key":"11556_CR48","doi-asserted-by":"crossref","unstructured":"Deka S, Kalita D, Paul M, Badoni G, Mathuria YP. Seroprevalence and determinants of ToRCH pathogens in pregnant women in the sub-Himalayan region. Cureus. 2022;14:1\u201312.","DOI":"10.7759\/cureus.21946"},{"key":"11556_CR49","first-page":"4","volume":"57","author":"A Mocanu","year":"2021","unstructured":"Mocanu A, Gorun F, Ciohat I, Navolan D, Malita D, Vilibic-Cavlek T, et al. Simultaneous Seroprevalence to Toxoplasma gondii, cytomegalovirus and Rubella virus in childbearing women from Western Romania. Med (B Aires). 2021;57:4\u201313.","journal-title":"Med (B Aires)"},{"key":"11556_CR50","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1034\/j.1600-0412.2000.079010824.x","volume":"79","author":"K Petersson","year":"2000","unstructured":"Petersson K, Stray-Pedersen B, Malm G, Forsgren M, Eveng\u00e5rd B. Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet Gynecol Scand. 2000;79:824\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"11556_CR51","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1017\/S0950268810001044","volume":"139","author":"A Hofhuis","year":"2011","unstructured":"Hofhuis A, Van Pelt W, Van Duynhoven Y, Nijhuis CDM, Mollema L, Van Der Klis FRM, et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in the Netherlands between 1995\/1996 and 2006\/2007. Epidemiol Infect. 2011;139:530\u20138.","journal-title":"Epidemiol Infect"},{"issue":"March","key":"11556_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2021.102402","volume":"84","author":"AS Deshmukh","year":"2021","unstructured":"Deshmukh AS, Hebbar BK, Mitra P, Shinde S, Chaudhari S, Barbuddhe SB. Seroprevalence and risk factors of Toxoplasma gondii infection among veterinary personnel and abattoir workers in central India. Parasitol Int. 2021;84(March): 102402.","journal-title":"Parasitol Int"},{"key":"11556_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ijgo.2011.10.029","volume":"116","author":"S Calimeri","year":"2012","unstructured":"Calimeri S, Capua A, La Fauci V, Squeri R, Grillo OC, Giudice D, Lo. Prevalence of serum anti-rubella virus antibodies among pregnant women in Southern Italy. Int J Gynecol Obstet. 2012;116:211\u20133.","journal-title":"Int J Gynecol Obstet"},{"key":"11556_CR54","unstructured":"Tanriverdi E\u00c7, D\u0130KBA\u015e L, Handan A, KADIO\u011eLU BG. \u00d6ZKURT Z. Seroprevalance of Rubella antibodies among pregnant women in a regional maternity hospital in Eastern Turkey. Mediterr J Infect Microbes Antimicrob. 2018;7:4\u20137."},{"key":"11556_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.inhe.2010.03.004","volume":"2","author":"M-D Amina","year":"2010","unstructured":"Amina M-D, Oladapo S, Habib S, Adebola O, Bimbo K, Daniel A. Prevalence of rubella IgG antibodies among pregnant women in Zaria, Nigeria. Int Health. 2010;2:156\u20139.","journal-title":"Int Health"},{"key":"11556_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3201\/eid2002.131233","volume":"20","author":"SI Pitts","year":"2014","unstructured":"Pitts SI, Wallace GS, Montana B, Handschur EF, Meislich D, Sampson AC, et al. Congenital rubella syndrome in child of woman without known risk factors, New Jersey, USA. Emerg Infect Dis. 2014;20:307.","journal-title":"Emerg Infect Dis"},{"key":"11556_CR57","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-3156.2006.01577.x","volume":"11","author":"J Barreto","year":"2006","unstructured":"Barreto J, Sacramento I, Robertson SE, Langa J, de Gourville E, Wolfson L, et al. Antenatal Rubella serosurvey in Maputo, Mozambique. Trop Med Int Health. 2006;11:559\u201364.","journal-title":"Trop Med Int Health"},{"key":"11556_CR58","doi-asserted-by":"publisher","first-page":"E43","DOI":"10.25011\/cim.v32i1.5086","volume":"32","author":"GS Tamer","year":"2009","unstructured":"Tamer GS, Dundar D, Caliskan E. Seroprevalence of Toxoplasma gondii, Rubella and cytomegalovirus among pregnant women in Western region of Turkey. Clin Invest Med. 2009;32:E43\u20137.","journal-title":"Clin Invest Med"},{"key":"11556_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/00365540600978880","volume":"39","author":"S Ocak","year":"2007","unstructured":"Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A. Seroprevalence of Toxoplasma gondii, Rubella and cytomegalovirus among pregnant women in Southern Turkey. Scand J Infect Dis. 2007;39:231\u20134.","journal-title":"Scand J Infect Dis"},{"key":"11556_CR60","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.puhe.2006.09.021","volume":"121","author":"E Pehlivan","year":"2007","unstructured":"Pehlivan E, Karaoglu L, Ozen M, Gunes G, Tekerekoglu MS, Genc MF, et al. Rubella seroprevalence in an unvaccinated pregnant population in Malatya, Turkey. Public Health. 2007;121:462\u20138.","journal-title":"Public Health"},{"key":"11556_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000065813","volume":"11","author":"HO Ghazi","year":"2002","unstructured":"Ghazi HO, Telmesani AM, Mahomed MF. TORCH agents in pregnant Saudi women. Med Princ Pract. 2002;11:180\u20132.","journal-title":"Med Princ Pract"},{"key":"11556_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15406\/jhvrv.2023.10.00256","volume":"10","author":"A Al-Thobhani","year":"2023","unstructured":"Al-Thobhani A, Abdullah QY, Alghalibi SM, Al-Arnoot S. Seroprevalence of rubella virus antibodies among pregnant women in Hodeidah city, Western Yemen. J Hum Virol Retrovirol. 2023;10:7\u201310.","journal-title":"J Hum Virol Retrovirol"},{"key":"11556_CR63","first-page":"112","volume":"1","author":"NF Abdulali","year":"2023","unstructured":"Abdulali NF. Seroprevalence of antibodies against to RCH infectious pathogens (Toxoplasma gondii, Rubella and cytomegalovirus) among pregnant women in El-Beida City. MISJ-International J Med Res Allied Sci. 2023;1:112\u201320.","journal-title":"MISJ-International J Med Res Allied Sci"},{"key":"11556_CR64","first-page":"8","volume":"6","author":"SB Josheghani","year":"2015","unstructured":"Josheghani SB, Moniri R, Taheri FB, Sadat S, Heidarzadeh Z. The prevalence of serum antibodies in TORCH infections during the first trimester of pregnancy in Kashan, Iran. Iran J Neonatol. 2015;6:8\u201312.","journal-title":"Iran J Neonatol"},{"key":"11556_CR65","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0313-2017","volume":"52","author":"JA Pribakovic","year":"2019","unstructured":"Pribakovic JA, Katanic N, Radevic T, Tasic MS, Kostic M, Stolic B, et al. Serological status of childbearing-aged women for Toxoplasma gondii and cytomegalovirus in Northern Kosovo and Metohija. Rev Soc Bras Med Trop. 2019;52: e\u201320170313.","journal-title":"Rev Soc Bras Med Trop"},{"key":"11556_CR66","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"A Kenneson","year":"2007","unstructured":"Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253\u201376.","journal-title":"Rev Med Virol"},{"key":"11556_CR67","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","volume":"20","author":"MJ Cannon","year":"2010","unstructured":"Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20:202\u201313.","journal-title":"Rev Med Virol"},{"key":"11556_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219922","volume":"14","author":"MT Frempong","year":"2019","unstructured":"Frempong MT, Ntiamoah P, Annani-Akollor ME, Owiredu WKBA, Addai-Mensah O, Owiredu E-W, et al. Hepatitis B and C infections in HIV-1 and non-HIV infected pregnant women in the Brong-Ahafo region, Ghana. PLoS One. 2019;14: e0219922.","journal-title":"PLoS One"},{"key":"11556_CR69","unstructured":"WHO. Global hepatitis report 2017. World Heal Organ Geneva. 2017."},{"key":"11556_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232208","volume":"15","author":"BA Dortey","year":"2020","unstructured":"Dortey BA, Anaba EA, Lassey AT, Damale NKR, Maya ET. Seroprevalence of hepatitis B virus infection and associated factors among pregnant women at Korle-Bu teaching hospital, Ghana. PLoS One. 2020;15: e0232208.","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"11556_CR71","first-page":"S213","volume":"5","author":"A Shoghli","year":"2014","unstructured":"Shoghli A, Nabavi SM, Alavian SM, Kolifarhood G, Goya MM, Namazi R, et al. Hepatitis B surface antigen prevalence in pregnant women: A cross-sectional survey in Iran. Int J Prev Med. 2014;5(Suppl 3):S213.","journal-title":"Int J Prev Med"},{"key":"11556_CR72","first-page":"424","volume":"3","author":"L Kheiri","year":"2015","unstructured":"Kheiri L, Makvandi S. The prevalence of hepatitis B surface antigen (HBsAg) and its influencing factors in pregnant women referring to healthcare centers of dehloran, Iran in 2011\u20132012. J Midwifery Reprod Health. 2015;3:424\u20139.","journal-title":"J Midwifery Reprod Health"},{"key":"11556_CR73","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5152\/tjg.2018.17634","volume":"30","author":"E\u00c7 Tanr\u0131verdi","year":"2018","unstructured":"Tanr\u0131verdi E\u00c7, \u00d6zkurt Z, Kad\u0131o\u011flu BG, Alay H, \u00c7al\u0131ko\u011flu O, Koca \u00d6, et al. Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. Turkish J Gastroenterol. 2018;30:260.","journal-title":"Turkish J Gastroenterol"},{"key":"11556_CR74","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1440-1746.1997.tb00365.x","volume":"12","author":"N Akbar","year":"1997","unstructured":"Akbar N, Basuki B, Garabrant DH, Sulaiman A, Noer HMS. MULYANTO. Ethnicity, socioeconomic status, transfusions and risk of hepatitis B and hepatitis C infection. J Gastroenterol Hepatol. 1997;12:752\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"11556_CR75","unstructured":"Alavian SM, Hajarizadeh B, Ahmadzadasl M, Kabir A, Bagheri LK. Hepatitis B Virus infection in Iran: A systematic review. 2008."},{"key":"11556_CR76","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4254\/wjh.v7.i3.289","volume":"7","author":"CMN Croagh","year":"2015","unstructured":"Croagh CMN, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol. 2015;7:289.","journal-title":"World J Hepatol"},{"key":"11556_CR77","volume":"9","author":"G Lucignani","year":"2022","unstructured":"Lucignani G, Guarnera A, Rossi-Espagnet MC, Moltoni G, Antonelli A, Fig\u00e0 Talamanca L, et al. From fetal to neonatal neuroimaging in TORCH infections: a pictorial review. Children (Basel). 2022;9: 1210.","journal-title":"Children (Basel)"},{"key":"11556_CR78","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.nainr.2004.01.001","volume":"4","author":"KM Boyer","year":"2004","unstructured":"Boyer KM, Boyer SG. Update on TORCH infections in the newborn infant. Newborn Infant Nurs Rev. 2004;4:70\u201380.","journal-title":"Newborn Infant Nurs Rev"},{"key":"11556_CR79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40556-019-00232-8","volume":"7","author":"P Batra","year":"2020","unstructured":"Batra P, Batra M, Singh S. Epidemiology of TORCH infections and understanding the serology in their diagnosis. J Fetal Med. 2020;7:25\u20139.","journal-title":"J Fetal Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11556-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11556-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11556-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T07:02:43Z","timestamp":1758092563000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11556-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11556"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11556-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For participants aging less than 16 years, informed consent to participate was obtained from their parents\/legal guardian. For participants aging 16 years or above, informed consent to participate was obtained from themselves. The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of University Tabriz (approval code: IR.Tabiz8.158, date: 12 March 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1112"}}